2.48
-0.03 (-1.2%)
-0.03 (-1.2%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.15
High
6.25
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.03 | -1.2% | 2.48 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.46 | 2.44 | 2.54 | 2.49 | 2.51 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.34 | 2.89 | 0.55 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 368 | 62,511 | $ 2.49 | $ 155,728 | - | 2.15 - 6.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:24:51 | formt | 100 | $ 2.48 | USD |
Period:
Draw Mode:
Galmed Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 52.36M | 21.11M | 17.58M | $ - | $ - | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Galmed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.755 | 2.755 | 2.37 | 2.50 | 81,106 | -0.275 | -9.98% |
| 1 Month | 3.21 | 3.27 | 2.37 | 2.75 | 89,871 | -0.73 | -22.74% |
| 3 Months | 2.54 | 4.08 | 2.15 | 3.19 | 247,555 | -0.06 | -2.36% |
| 6 Months | 3.77 | 6.25 | 2.15 | 3.82 | 341,851 | -1.29 | -34.22% |
| 1 Year | 4.53 | 6.25 | 2.15 | 3.80 | 221,785 | -2.05 | -45.25% |
| 3 Years | 13.36 | 14.6495 | 2.15 | 5.64 | 144,543 | -10.88 | -81.44% |
| 5 Years | 4.4712 | 27.06 | 2.15 | 8.32 | 145,770 | -1.99 | -44.53% |
Galmed Pharmaceuticals Description
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. |
